Search
for
Sort by
Research 871–900 of 1000+
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- Investigation on antimicrobial, antioxidant, and anti-cancerous activity of Agaricus bisporus derived β-Glucan against cervical cancer cell line
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- MSF-VMDNet for multi class segmentation of skin cancer whole slide images using a multi frequency dual encoder network
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Epigenetic regulation in adult stem cells and cancers
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Dermatologic Adverse Events from Cancer Treatments
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Redefining hormone resistance in prostate cancer
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Slow progress in prostate cancer
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality